{"entity":{"type":"insider","cik":"0001730048","url":"/insider/0001730048","json_url":"/insider/0001730048.json","name":"Hopkinson Craig C.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":29,"n_filings":24,"first":"2021-04-16","last":"2026-08-03","span_basis":"filed_date"},"name_variants":[{"name":"Hopkinson Craig C.","source":"filing","n_filings":24,"first_seen":"2021-04-16","last_seen":"2026-08-03"}],"transactions":[{"id":6148815,"accession":"0001520262-26-000110","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001520262-26-000110","line_url":"/filing/0001520262-26-000110#line-3","is_derivative":false,"issuer_cik":"0001520262","issuer_name":"Alkermes plc.","issuer_ticker":"ALKS","issuer_name_source":null,"issuer_url":"/issuer/0001520262","owner_cik":"0001730048","owner_name":"Hopkinson Craig C.","owner_display_name":"Hopkinson Craig C.","owner_url":"/insider/0001730048","role":"Officer (EVP R&D, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP R&D, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP R&D, Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":48.58,"price_display":"48.58","price_state":"stated","total_value":437220.0,"total_display":"437,220.00","total_whole":"437,220","shares_owned_after":69389.0,"shares_owned_after_display":"69,389","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-03","filed_date":"2026-08-03","scope":"insider"},{"id":6054601,"accession":"0001520262-26-000103","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001520262-26-000103","line_url":"/filing/0001520262-26-000103","is_derivative":false,"issuer_cik":"0001520262","issuer_name":"Alkermes plc.","issuer_ticker":"ALKS","issuer_name_source":null,"issuer_url":"/issuer/0001520262","owner_cik":"0001730048","owner_name":"Hopkinson Craig C.","owner_display_name":"Hopkinson Craig C.","owner_url":"/insider/0001730048","role":"Officer (EVP R&D, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP R&D, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP R&D, Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":51.513418888888886,"price_display":"51.51","price_state":"stated","total_value":463620.77,"total_display":"463,620.77","total_whole":"463,621","shares_owned_after":74089.0,"shares_owned_after_display":"74,089","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-01","filed_date":"2026-07-01","scope":"insider","n_lines":2},{"id":6022068,"accession":"0001520262-26-000097","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001520262-26-000097","line_url":"/filing/0001520262-26-000097#line-2","is_derivative":false,"issuer_cik":"0001520262","issuer_name":"Alkermes plc.","issuer_ticker":"ALKS","issuer_name_source":null,"issuer_url":"/issuer/0001520262","owner_cik":"0001730048","owner_name":"Hopkinson Craig C.","owner_display_name":"Hopkinson Craig C.","owner_url":"/insider/0001730048","role":"Officer (EVP R&D, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP R&D, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP R&D, Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":41.6715,"price_display":"41.67","price_state":"stated","total_value":375043.5,"total_display":"375,043.50","total_whole":"375,044","shares_owned_after":77389.0,"shares_owned_after_display":"77,389","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-01","filed_date":"2026-06-01","scope":"insider"},{"id":5765907,"accession":"0001520262-26-000072","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001520262-26-000072","line_url":"/filing/0001520262-26-000072#line-2","is_derivative":false,"issuer_cik":"0001520262","issuer_name":"Alkermes plc.","issuer_ticker":"ALKS","issuer_name_source":null,"issuer_url":"/issuer/0001520262","owner_cik":"0001730048","owner_name":"Hopkinson Craig C.","owner_display_name":"Hopkinson Craig C.","owner_url":"/insider/0001730048","role":"Officer (EVP R&D, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP R&D, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP R&D, Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":33.3955,"price_display":"33.40","price_state":"stated","total_value":300559.5,"total_display":"300,559.50","total_whole":"300,560","shares_owned_after":81389.0,"shares_owned_after_display":"81,389","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-01","filed_date":"2026-05-01","scope":"insider"},{"id":5862664,"accession":"0001520262-26-000065","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001520262-26-000065","line_url":"/filing/0001520262-26-000065#line-2","is_derivative":false,"issuer_cik":"0001520262","issuer_name":"Alkermes plc.","issuer_ticker":"ALKS","issuer_name_source":null,"issuer_url":"/issuer/0001520262","owner_cik":"0001730048","owner_name":"Hopkinson Craig C.","owner_display_name":"Hopkinson Craig C.","owner_url":"/insider/0001730048","role":"Officer (EVP R&D, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP R&D, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP R&D, Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":35.5116,"price_display":"35.51","price_state":"stated","total_value":319604.4,"total_display":"319,604.40","total_whole":"319,604","shares_owned_after":85389.0,"shares_owned_after_display":"85,389","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-01","filed_date":"2026-04-01","scope":"insider"},{"id":6130573,"accession":"0001520262-26-000058","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001520262-26-000058","line_url":"/filing/0001520262-26-000058#line-2","is_derivative":false,"issuer_cik":"0001520262","issuer_name":"Alkermes plc.","issuer_ticker":"ALKS","issuer_name_source":null,"issuer_url":"/issuer/0001520262","owner_cik":"0001730048","owner_name":"Hopkinson Craig C.","owner_display_name":"Hopkinson Craig C.","owner_url":"/insider/0001730048","role":"Officer (EVP R&D, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP R&D, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP R&D, Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":29.7206,"price_display":"29.72","price_state":"stated","total_value":267485.4,"total_display":"267,485.40","total_whole":"267,485","shares_owned_after":89389.0,"shares_owned_after_display":"89,389","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider"},{"id":5947205,"accession":"0001520262-26-000009","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001520262-26-000009","line_url":"/filing/0001520262-26-000009","is_derivative":false,"issuer_cik":"0001520262","issuer_name":"Alkermes plc.","issuer_ticker":"ALKS","issuer_name_source":null,"issuer_url":"/issuer/0001520262","owner_cik":"0001730048","owner_name":"Hopkinson Craig C.","owner_display_name":"Hopkinson Craig C.","owner_url":"/insider/0001730048","role":"Officer (EVP R&D, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP R&D, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP R&D, Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":33.93161111111111,"price_display":"33.93","price_state":"stated","total_value":305384.5,"total_display":"305,384.50","total_whole":"305,385","shares_owned_after":61740.0,"shares_owned_after_display":"61,740","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-02","filed_date":"2026-02-02","scope":"insider","n_lines":2},{"id":5824255,"accession":"0001520262-26-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001520262-26-000004","line_url":"/filing/0001520262-26-000004#line-2","is_derivative":false,"issuer_cik":"0001520262","issuer_name":"Alkermes plc.","issuer_ticker":"ALKS","issuer_name_source":null,"issuer_url":"/issuer/0001520262","owner_cik":"0001730048","owner_name":"Hopkinson Craig C.","owner_display_name":"Hopkinson Craig C.","owner_url":"/insider/0001730048","role":"Officer (EVP R&D, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP R&D, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP R&D, Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":30.001,"price_display":"30.00","price_state":"stated","total_value":150005.0,"total_display":"150,005.00","total_whole":"150,005","shares_owned_after":61740.0,"shares_owned_after_display":"61,740","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-08","filed_date":"2026-01-08","scope":"insider"},{"id":6167279,"accession":"0001520262-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001520262-26-000002","line_url":"/filing/0001520262-26-000002#line-1","is_derivative":false,"issuer_cik":"0001520262","issuer_name":"Alkermes plc.","issuer_ticker":"ALKS","issuer_name_source":null,"issuer_url":"/issuer/0001520262","owner_cik":"0001730048","owner_name":"Hopkinson Craig C.","owner_display_name":"Hopkinson Craig C.","owner_url":"/insider/0001730048","role":"Officer (EVP R&D, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP R&D, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP R&D, Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":28.0,"price_display":"28.00","price_state":"stated","total_value":112000.0,"total_display":"112,000.00","total_whole":"112,000","shares_owned_after":61740.0,"shares_owned_after_display":"61,740","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-02","filed_date":"2026-01-02","scope":"insider"},{"id":4514309,"accession":"0001520262-25-000014","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001520262-25-000014","line_url":"/filing/0001520262-25-000014#line-2","is_derivative":false,"issuer_cik":"0001520262","issuer_name":"Alkermes plc.","issuer_ticker":"ALKS","issuer_name_source":null,"issuer_url":"/issuer/0001520262","owner_cik":"0001730048","owner_name":"Hopkinson Craig C.","owner_display_name":"Hopkinson Craig C.","owner_url":"/insider/0001730048","role":"Officer (EVP R&D, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP R&D, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP R&D, Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3748.0,"shares_display":"3,748","price_per_share":30.0019,"price_display":"30.00","price_state":"stated","total_value":112447.1212,"total_display":"112,447.12","total_whole":"112,447","shares_owned_after":65740.0,"shares_owned_after_display":"65,740","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-03","filed_date":"2025-12-05","scope":"insider"},{"id":4152553,"accession":"0001520262-25-000012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001520262-25-000012","line_url":"/filing/0001520262-25-000012#line-1","is_derivative":false,"issuer_cik":"0001520262","issuer_name":"Alkermes plc.","issuer_ticker":"ALKS","issuer_name_source":null,"issuer_url":"/issuer/0001520262","owner_cik":"0001730048","owner_name":"Hopkinson Craig C.","owner_display_name":"Hopkinson Craig C.","owner_url":"/insider/0001730048","role":"Officer (EVP R&D, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP R&D, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP R&D, Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":29.3,"price_display":"29.30","price_state":"stated","total_value":117200.0,"total_display":"117,200.00","total_whole":"117,200","shares_owned_after":65740.0,"shares_owned_after_display":"65,740","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-01","filed_date":"2025-12-01","scope":"insider"},{"id":4152550,"accession":"0001520262-25-000010","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001520262-25-000010","line_url":"/filing/0001520262-25-000010#line-2","is_derivative":false,"issuer_cik":"0001520262","issuer_name":"Alkermes plc.","issuer_ticker":"ALKS","issuer_name_source":null,"issuer_url":"/issuer/0001520262","owner_cik":"0001730048","owner_name":"Hopkinson Craig C.","owner_display_name":"Hopkinson Craig C.","owner_url":"/insider/0001730048","role":"Officer (EVP R&D, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP R&D, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP R&D, Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":30.3824,"price_display":"30.38","price_state":"stated","total_value":273441.6,"total_display":"273,441.60","total_whole":"273,442","shares_owned_after":69740.0,"shares_owned_after_display":"69,740","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-03","filed_date":"2025-11-03","scope":"insider"},{"id":4257967,"accession":"0001520262-25-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001520262-25-000008","line_url":"/filing/0001520262-25-000008#line-2","is_derivative":false,"issuer_cik":"0001520262","issuer_name":"Alkermes plc.","issuer_ticker":"ALKS","issuer_name_source":null,"issuer_url":"/issuer/0001520262","owner_cik":"0001730048","owner_name":"Hopkinson Craig C.","owner_display_name":"Hopkinson Craig C.","owner_url":"/insider/0001730048","role":"Officer (EVP R&D, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP R&D, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP R&D, Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":31.5307,"price_display":"31.53","price_state":"stated","total_value":283776.3,"total_display":"283,776.30","total_whole":"283,776","shares_owned_after":73740.0,"shares_owned_after_display":"73,740","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-15","filed_date":"2025-10-15","scope":"insider"},{"id":4511511,"accession":"0001127602-25-004948","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001127602-25-004948","line_url":"/filing/0001127602-25-004948","is_derivative":false,"issuer_cik":"0001520262","issuer_name":"Alkermes plc.","issuer_ticker":"ALKS","issuer_name_source":null,"issuer_url":"/issuer/0001520262","owner_cik":"0001730048","owner_name":"Hopkinson Craig C.","owner_display_name":"Hopkinson Craig C.","owner_url":"/insider/0001730048","role":"Officer (EVP R&D, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP R&D, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP R&D, Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":144419.0,"shares_display":"144,419","price_per_share":35.526472463457026,"price_display":"35.53","price_state":"stated","total_value":5130697.6267,"total_display":"5,130,697.63","total_whole":"5,130,698","shares_owned_after":57875.0,"shares_owned_after_display":"57,875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-13","filed_date":"2025-02-14","scope":"insider","n_lines":2},{"id":4511496,"accession":"0001127602-25-004948","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-25-004948","line_url":"/filing/0001127602-25-004948","is_derivative":false,"issuer_cik":"0001520262","issuer_name":"Alkermes plc.","issuer_ticker":"ALKS","issuer_name_source":null,"issuer_url":"/issuer/0001520262","owner_cik":"0001730048","owner_name":"Hopkinson Craig C.","owner_display_name":"Hopkinson Craig C.","owner_url":"/insider/0001730048","role":"Officer (EVP R&D, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP R&D, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP R&D, Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":204921.0,"shares_display":"204,921","price_per_share":32.784719771033714,"price_display":"32.78","price_state":"stated","total_value":6718277.5602,"total_display":"6,718,277.56","total_whole":"6,718,278","shares_owned_after":90983.0,"shares_owned_after_display":"90,983","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-12","filed_date":"2025-02-14","scope":"insider","n_lines":2},{"id":4423107,"accession":"0001127602-25-002645","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001127602-25-002645","line_url":"/filing/0001127602-25-002645#line-5","is_derivative":false,"issuer_cik":"0001520262","issuer_name":"Alkermes plc.","issuer_ticker":"ALKS","issuer_name_source":null,"issuer_url":"/issuer/0001520262","owner_cik":"0001730048","owner_name":"Hopkinson Craig C.","owner_display_name":"Hopkinson Craig C.","owner_url":"/insider/0001730048","role":"Officer (EVP R&D, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP R&D, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP R&D, Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100918.0,"shares_display":"100,918","price_per_share":32.0496,"price_display":"32.05","price_state":"stated","total_value":3234381.5328,"total_display":"3,234,381.53","total_whole":"3,234,382","shares_owned_after":44290.0,"shares_owned_after_display":"44,290","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-30","filed_date":"2025-01-31","scope":"insider"},{"id":2349109,"accession":"0001127602-24-028885","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001127602-24-028885","line_url":"/filing/0001127602-24-028885#line-5","is_derivative":false,"issuer_cik":"0001520262","issuer_name":"Alkermes plc.","issuer_ticker":"ALKS","issuer_name_source":null,"issuer_url":"/issuer/0001520262","owner_cik":"0001730048","owner_name":"Hopkinson Craig C.","owner_display_name":"Hopkinson Craig C.","owner_url":"/insider/0001730048","role":"Officer (EVP R&D, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP R&D, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP R&D, Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":61151.0,"shares_display":"61,151","price_per_share":32.0748,"price_display":"32.07","price_state":"stated","total_value":1961406.0948,"total_display":"1,961,406.09","total_whole":"1,961,406","shares_owned_after":47576.0,"shares_owned_after_display":"47,576","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-09","filed_date":"2024-12-09","scope":"insider"},{"id":3159491,"accession":"0001127602-24-028740","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-028740","line_url":"/filing/0001127602-24-028740#line-1","is_derivative":false,"issuer_cik":"0001520262","issuer_name":"Alkermes plc.","issuer_ticker":"ALKS","issuer_name_source":null,"issuer_url":"/issuer/0001520262","owner_cik":"0001730048","owner_name":"Hopkinson Craig C.","owner_display_name":"Hopkinson Craig C.","owner_url":"/insider/0001730048","role":"Officer (EVP R&D, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP R&D, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP R&D, Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9221.0,"shares_display":"9,221","price_per_share":31.5,"price_display":"31.50","price_state":"stated","total_value":290461.5,"total_display":"290,461.50","total_whole":"290,462","shares_owned_after":59730.0,"shares_owned_after_display":"59,730","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-05","filed_date":"2024-12-05","scope":"insider"},{"id":2263456,"accession":"0001127602-24-028647","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-028647","line_url":"/filing/0001127602-24-028647#line-1","is_derivative":false,"issuer_cik":"0001520262","issuer_name":"Alkermes plc.","issuer_ticker":"ALKS","issuer_name_source":null,"issuer_url":"/issuer/0001520262","owner_cik":"0001730048","owner_name":"Hopkinson Craig C.","owner_display_name":"Hopkinson Craig C.","owner_url":"/insider/0001730048","role":"Officer (EVP R&D, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP R&D, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP R&D, Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14349.0,"shares_display":"14,349","price_per_share":30.7722,"price_display":"30.77","price_state":"stated","total_value":441550.2978,"total_display":"441,550.30","total_whole":"441,550","shares_owned_after":68951.0,"shares_owned_after_display":"68,951","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-04","filed_date":"2024-12-04","scope":"insider"},{"id":2980095,"accession":"0001127602-24-027044","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-24-027044","line_url":"/filing/0001127602-24-027044#line-2","is_derivative":false,"issuer_cik":"0001520262","issuer_name":"Alkermes plc.","issuer_ticker":"ALKS","issuer_name_source":null,"issuer_url":"/issuer/0001520262","owner_cik":"0001730048","owner_name":"Hopkinson Craig C.","owner_display_name":"Hopkinson Craig C.","owner_url":"/insider/0001730048","role":"Officer (EVP R&D, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP R&D, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP R&D, Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":58996.0,"shares_display":"58,996","price_per_share":30.0796,"price_display":"30.08","price_state":"stated","total_value":1774576.0816,"total_display":"1,774,576.08","total_whole":"1,774,576","shares_owned_after":83300.0,"shares_owned_after_display":"83,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-11","filed_date":"2024-11-12","scope":"insider"},{"id":2785151,"accession":"0001127602-24-026629","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-026629","line_url":"/filing/0001127602-24-026629#line-1","is_derivative":false,"issuer_cik":"0001520262","issuer_name":"Alkermes plc.","issuer_ticker":"ALKS","issuer_name_source":null,"issuer_url":"/issuer/0001520262","owner_cik":"0001730048","owner_name":"Hopkinson Craig C.","owner_display_name":"Hopkinson Craig C.","owner_url":"/insider/0001730048","role":"Officer (EVP R&D, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP R&D, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP R&D, Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10471.0,"shares_display":"10,471","price_per_share":29.5262,"price_display":"29.53","price_state":"stated","total_value":309168.8402,"total_display":"309,168.84","total_whole":"309,169","shares_owned_after":99238.0,"shares_owned_after_display":"99,238","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-06","filed_date":"2024-11-06","scope":"insider"},{"id":6463008,"accession":"0001127602-22-006622","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-22-006622","line_url":"/filing/0001127602-22-006622#line-1","is_derivative":false,"issuer_cik":"0001520262","issuer_name":"Alkermes plc.","issuer_ticker":"ALKS","issuer_name_source":null,"issuer_url":"/issuer/0001520262","owner_cik":"0001730048","owner_name":"Hopkinson Craig C.","owner_display_name":"Hopkinson Craig C.","owner_url":"/insider/0001730048","role":"Officer (EVP R&D, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP R&D, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP R&D, Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11983.0,"shares_display":"11,983","price_per_share":24.7559,"price_display":"24.76","price_state":"stated","total_value":296649.9497,"total_display":"296,649.95","total_whole":"296,650","shares_owned_after":17994.0,"shares_owned_after_display":"17,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-23","filed_date":"2022-02-24","scope":"insider"},{"id":6151822,"accession":"0001127602-22-006332","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-22-006332","line_url":"/filing/0001127602-22-006332#line-1","is_derivative":false,"issuer_cik":"0001520262","issuer_name":"Alkermes plc.","issuer_ticker":"ALKS","issuer_name_source":null,"issuer_url":"/issuer/0001520262","owner_cik":"0001730048","owner_name":"Hopkinson Craig C.","owner_display_name":"Hopkinson Craig C.","owner_url":"/insider/0001730048","role":"Officer (EVP R&D, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP R&D, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP R&D, Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2306.0,"shares_display":"2,306","price_per_share":25.17,"price_display":"25.17","price_state":"stated","total_value":58042.02,"total_display":"58,042.02","total_whole":"58,042","shares_owned_after":9496.0,"shares_owned_after_display":"9,496","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-18","filed_date":"2022-02-23","scope":"insider"},{"id":5449993,"accession":"0001127602-21-019721","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-21-019721","line_url":"/filing/0001127602-21-019721#line-1","is_derivative":false,"issuer_cik":"0001520262","issuer_name":"Alkermes plc.","issuer_ticker":"ALKS","issuer_name_source":null,"issuer_url":"/issuer/0001520262","owner_cik":"0001730048","owner_name":"Hopkinson Craig C.","owner_display_name":"Hopkinson Craig C.","owner_url":"/insider/0001730048","role":"Officer (EVP R&D, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP R&D, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP R&D, Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":882.0,"shares_display":"882","price_per_share":24.6,"price_display":"24.60","price_state":"stated","total_value":21697.2,"total_display":"21,697.20","total_whole":"21,697","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-09","filed_date":"2021-06-11","scope":"insider"},{"id":5537920,"accession":"0001127602-21-013891","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-21-013891","line_url":"/filing/0001127602-21-013891#line-1","is_derivative":false,"issuer_cik":"0001520262","issuer_name":"Alkermes plc.","issuer_ticker":"ALKS","issuer_name_source":null,"issuer_url":"/issuer/0001520262","owner_cik":"0001730048","owner_name":"Hopkinson Craig C.","owner_display_name":"Hopkinson Craig C.","owner_url":"/insider/0001730048","role":"Officer (EVP R&D, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP R&D, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP R&D, Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28920.0,"shares_display":"28,920","price_per_share":19.7195,"price_display":"19.72","price_state":"stated","total_value":570287.94,"total_display":"570,287.94","total_whole":"570,288","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-15","filed_date":"2021-04-16","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":29,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":29,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":29},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001520262","name":"Alkermes plc.","url":"/issuer/0001520262","role":"Officer (EVP R&D, Chief Medical Officer)","n_filings":24,"first_seen":"2021-04-16","last_seen":"2026-08-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001730048","retrieved_at":"2026-08-25T00:59:42+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}